Use of biomarkers in the context of orphan medicines designation in the European Union
2014 · Orphanet Journal of Rare Diseases · 12 citations
https://doi.org/10.1186/1750-1172-9-13
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
972
Citations
12
h-index
15
i10-index
Stelios Tsigkos is an academic researcher from European Medicines Agency. The author has contributed to research in topics: Angiogenesis and VEGF in Cancer & Health Systems, Economic Evaluations, Quality of Life & Pharmaceutical Economics and Policy. The author has an h-index of 12, co-authored 21 publications.
Click to start Chat